Topiramate therapy for paroxysmal kinesigenic choreoathetosis.
Identifieur interne : 002F31 ( PubMed/Checkpoint ); précédent : 002F30; suivant : 002F32Topiramate therapy for paroxysmal kinesigenic choreoathetosis.
Auteurs : Yuan-Gui Huang [République populaire de Chine] ; Yun-Chun Chen ; Fang Du ; Rui Li ; Ge-Lin Xu ; Wen Jiang ; Jing HuangSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2005.
English descriptors
- KwdEn :
- Adolescent, Adult, Anticonvulsants (therapeutic use), Athetosis (complications), Athetosis (drug therapy), Child, Chorea (complications), Chorea (drug therapy), Dose-Response Relationship, Drug, Female, Follow-Up Studies, Fructose (analogs & derivatives), Fructose (therapeutic use), Humans, Male, Treatment Outcome.
- MESH :
- chemical , analogs & derivatives : Fructose.
- chemical , therapeutic use : Anticonvulsants, Fructose.
- complications : Athetosis, Chorea.
- drug therapy : Athetosis, Chorea.
- Adolescent, Adult, Child, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Male, Treatment Outcome.
Abstract
We observed the clinical efficacy of topiramate for paroxysmal kinesigenic choreoathetosis (PKC). Topiramate was administered as a monotherapy with titrated dosages to 8 patients with PKC. Target daily dose of topiramate was 100 to 200 mg; the follow-up period ranged from 8 months to 2 years. All of the patients became attack-free, and side effects were mild. The results show that topiramate is effective as a monotherapy for treating patients with PKC. The response to topiramate indicates that the disease may be caused by an ion channel defect.
DOI: 10.1002/mds.20283
PubMed: 15390133
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15390133Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Topiramate therapy for paroxysmal kinesigenic choreoathetosis.</title>
<author><name sortKey="Huang, Yuan Gui" sort="Huang, Yuan Gui" uniqKey="Huang Y" first="Yuan-Gui" last="Huang">Yuan-Gui Huang</name>
<affiliation wicri:level="1"><nlm:affiliation>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi</wicri:regionArea>
<wicri:noRegion>Shaanxi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chen, Yun Chun" sort="Chen, Yun Chun" uniqKey="Chen Y" first="Yun-Chun" last="Chen">Yun-Chun Chen</name>
</author>
<author><name sortKey="Du, Fang" sort="Du, Fang" uniqKey="Du F" first="Fang" last="Du">Fang Du</name>
</author>
<author><name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
</author>
<author><name sortKey="Xu, Ge Lin" sort="Xu, Ge Lin" uniqKey="Xu G" first="Ge-Lin" last="Xu">Ge-Lin Xu</name>
</author>
<author><name sortKey="Jiang, Wen" sort="Jiang, Wen" uniqKey="Jiang W" first="Wen" last="Jiang">Wen Jiang</name>
</author>
<author><name sortKey="Huang, Jing" sort="Huang, Jing" uniqKey="Huang J" first="Jing" last="Huang">Jing Huang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15390133</idno>
<idno type="pmid">15390133</idno>
<idno type="doi">10.1002/mds.20283</idno>
<idno type="wicri:Area/PubMed/Corpus">003228</idno>
<idno type="wicri:Area/PubMed/Curation">003228</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F31</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Topiramate therapy for paroxysmal kinesigenic choreoathetosis.</title>
<author><name sortKey="Huang, Yuan Gui" sort="Huang, Yuan Gui" uniqKey="Huang Y" first="Yuan-Gui" last="Huang">Yuan-Gui Huang</name>
<affiliation wicri:level="1"><nlm:affiliation>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi</wicri:regionArea>
<wicri:noRegion>Shaanxi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chen, Yun Chun" sort="Chen, Yun Chun" uniqKey="Chen Y" first="Yun-Chun" last="Chen">Yun-Chun Chen</name>
</author>
<author><name sortKey="Du, Fang" sort="Du, Fang" uniqKey="Du F" first="Fang" last="Du">Fang Du</name>
</author>
<author><name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
</author>
<author><name sortKey="Xu, Ge Lin" sort="Xu, Ge Lin" uniqKey="Xu G" first="Ge-Lin" last="Xu">Ge-Lin Xu</name>
</author>
<author><name sortKey="Jiang, Wen" sort="Jiang, Wen" uniqKey="Jiang W" first="Wen" last="Jiang">Wen Jiang</name>
</author>
<author><name sortKey="Huang, Jing" sort="Huang, Jing" uniqKey="Huang J" first="Jing" last="Huang">Jing Huang</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Athetosis (complications)</term>
<term>Athetosis (drug therapy)</term>
<term>Child</term>
<term>Chorea (complications)</term>
<term>Chorea (drug therapy)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Fructose (analogs & derivatives)</term>
<term>Fructose (therapeutic use)</term>
<term>Humans</term>
<term>Male</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Fructose</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticonvulsants</term>
<term>Fructose</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Athetosis</term>
<term>Chorea</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Athetosis</term>
<term>Chorea</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We observed the clinical efficacy of topiramate for paroxysmal kinesigenic choreoathetosis (PKC). Topiramate was administered as a monotherapy with titrated dosages to 8 patients with PKC. Target daily dose of topiramate was 100 to 200 mg; the follow-up period ranged from 8 months to 2 years. All of the patients became attack-free, and side effects were mild. The results show that topiramate is effective as a monotherapy for treating patients with PKC. The response to topiramate indicates that the disease may be caused by an ion channel defect.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">15390133</PMID>
<DateCreated><Year>2005</Year>
<Month>01</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>05</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>08</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>20</Volume>
<Issue>1</Issue>
<PubDate><Year>2005</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Topiramate therapy for paroxysmal kinesigenic choreoathetosis.</ArticleTitle>
<Pagination><MedlinePgn>75-7</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We observed the clinical efficacy of topiramate for paroxysmal kinesigenic choreoathetosis (PKC). Topiramate was administered as a monotherapy with titrated dosages to 8 patients with PKC. Target daily dose of topiramate was 100 to 200 mg; the follow-up period ranged from 8 months to 2 years. All of the patients became attack-free, and side effects were mild. The results show that topiramate is effective as a monotherapy for treating patients with PKC. The response to topiramate indicates that the disease may be caused by an ion channel defect.</AbstractText>
<CopyrightInformation>(c) 2004 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Yuan-Gui</ForeName>
<Initials>YG</Initials>
<AffiliationInfo><Affiliation>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Yun-Chun</ForeName>
<Initials>YC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Du</LastName>
<ForeName>Fang</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Rui</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Xu</LastName>
<ForeName>Ge-Lin</ForeName>
<Initials>GL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jiang</LastName>
<ForeName>Wen</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0H73WJJ391</RegistryNumber>
<NameOfSubstance UI="C052342">topiramate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>30237-26-4</RegistryNumber>
<NameOfSubstance UI="D005632">Fructose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001264">Athetosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002819">Chorea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005632">Fructose</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs & derivatives</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>5</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15390133</ArticleId>
<ArticleId IdType="doi">10.1002/mds.20283</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Chen, Yun Chun" sort="Chen, Yun Chun" uniqKey="Chen Y" first="Yun-Chun" last="Chen">Yun-Chun Chen</name>
<name sortKey="Du, Fang" sort="Du, Fang" uniqKey="Du F" first="Fang" last="Du">Fang Du</name>
<name sortKey="Huang, Jing" sort="Huang, Jing" uniqKey="Huang J" first="Jing" last="Huang">Jing Huang</name>
<name sortKey="Jiang, Wen" sort="Jiang, Wen" uniqKey="Jiang W" first="Wen" last="Jiang">Wen Jiang</name>
<name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
<name sortKey="Xu, Ge Lin" sort="Xu, Ge Lin" uniqKey="Xu G" first="Ge-Lin" last="Xu">Ge-Lin Xu</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Huang, Yuan Gui" sort="Huang, Yuan Gui" uniqKey="Huang Y" first="Yuan-Gui" last="Huang">Yuan-Gui Huang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F31 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002F31 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:15390133 |texte= Topiramate therapy for paroxysmal kinesigenic choreoathetosis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15390133" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |